5 Recruiting Myelofibrosis Phase 3 Clinical Trials
Active phase 3 studies for myelofibrosis enrolling across the USA. Verify eligibility and contact site coordinators.
All Myelofibrosis studiesPhase 3 Studies for Myelofibrosis
🔵 Active, Not Recruiting Phase3
Study of Selinexor in Combination With Ruxolitinib in Myelofibrosis
📍 UAB Division of Hematology/Oncology — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
Phase 3 Study of Pelabresib (CPI-0610) in Myelofibrosis (MF) (MANIFEST-2)
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
A Study Comparing Imetelstat Versus Best Available Therapy for the Treatment of Intermediate-2 or High-risk Myelofibrosis (MF) Who Have Not Responded to Janus Kinase (JAK)-Inhibitor Treatment
📍 University of California-San Diego/Moores UCSD Cancer Center — La Jolla, California
View Study & Checklist ➔ 🟢 Recruiting Phase3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
📍 UAB Hospital — Birmingham, Alabama
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔